Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 40 and up

Comparing different intraocular lenses for cataract surgery

Official title: A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

Run by Berkeley Eye Center · NCT06922084 · Data updated 2026-11-12

This study is testing three different types of lenses used in cataract surgery to see which one helps people see better after the procedure.

Quick facts

PhasePhase 4
Study typeInterventional
Ages40 Years and up
SexAll
Enrollment320 (estimated)
SponsorBerkeley Eye Center
Academic / other
Locations2 sites (Plymouth Meeting, Pennsylvania and 1 other locations)
StatusRecruiting
StartedMarch 17, 2025
Main results expectedApril 2027
Study endsApril 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT06922084 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40 and older who are scheduled for cataract surgery in both eyes and meet specific visual acuity and astigmatism criteria.

Probably not a fit

Patients with significant ocular conditions or those who are pregnant or breastfeeding may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study is a prospective, randomized, multicenter trial that evaluates the effectiveness of three types of intraocular lenses: Clareon PanOptix, Clareon PanOptix Pro, and a mix of Clareon PanOptix Pro/Vivity in patients undergoing cataract surgery. The study is designed in two stages, with the first stage involving initial enrollment across three arms, followed by a head-to-head comparison based on the data collected. Participants will be masked to the treatment they receive, and the study aims to assess visual outcomes post-surgery.

Why it matters

Potential benefit: If successful, this study could provide insights into the best intraocular lens options for improved visual outcomes in cataract patients.

How similar studies have gone: Other studies have explored various intraocular lenses, but this specific comparison of these three types is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult cataract patients aged 40 years and older scheduled for age related cataract surgery in both eyes.
* Ability to understand and sign an ethics committee-approved informed consent form.
* Willingness and ability to attend all scheduled study visits as required by the protocol.
* Postoperative potential visual acuity of 20/25 or better in each eye, as determined by the investigator.
* Preoperative corneal astigmatism that can be corrected with a T3 or T4 toric IOL, or with a spherical IOL and LRIs or AKs resulting in a predicted postoperative astigmatism of less than 0.5 diopters (D).
* Ability to understand and complete questionnaires.

Exclusion Criteria:

* Women who are pregnant, planning to become pregnant during the study, or breastfeeding.
* Ocular conditions that could confound study results, including moderate to severe corneal pathology, irregular astigmatism, moderate to severe dry eye, preexisting retinal diseases such as macular degeneration or diabetic retinopathy.
* Any form of confirmed glaucomatous damage (ie, mild, moderate, or severe glaucoma).
* Participation in another clinical study that could interfere with the results.
* Systemic conditions that may affect healing or visual outcomes (e.g., uncontrolled diabetes mellitus, certain autoimmune disorders).
* Subjects with nystagmus, strabismus, zonular laxity or dehiscence, and pseudoexfoliation.
* Prior ocular surgery (except for uncomplicated cataract surgery in the fellow eye).
* Participants desiring monovision.
* Any active ocular infection or inflammation (except for routine post-operative inflammation in the fellow eye)
* Psychiatric or cognitive disorders that may impair the ability to comply with study procedures or provide accurate self-assessments.
* RMS total higher-order aberrations (HOAs) \>0.70 µm or coma \>0.40 µm as measured by tomography or topography with a 4 mm pupil setting.

Where it's running

  • Shafer Vision Institute
    Plymouth Meeting, Pennsylvania, United States
    Recruiting
  • Berkeley Eye Center
    Houston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.